How Do Oncologists Determine the Need for Cardioprotective Agents?
The decision to use cardioprotective agents is based on several factors, including the patient's cardiovascular risk profile, the type and dose of chemotherapy, and the presence of pre-existing heart conditions. Oncologists may use echocardiograms, biomarkers like troponin, and other diagnostic tools to monitor heart health and decide on the appropriate cardioprotective strategy.
